FDA and EMA mostly align on GCP inspection deficiencies, study finds

Regulatory NewsRegulatory NewsAudit/inspectionClinical TrialsComplianceEuropeNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development